Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Balaji Amines's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 2,742.54 | 2,252.06 | 2,146.15 |
| Accumulated Depreciation Total | -465.3 | -410.41 | -363.45 |
| Other Liabilities Total | 9.79 | 3.73 | 6.1 |
| Accrued Expenses | 29.9 | 26.05 | 31.74 |
| Long Term Debt | 64.83 | 1.52 | 10.61 |
| Common Stock Total | 6.48 | 6.48 | 6.48 |
| Other Current Assets Total | 1.58 | 5.02 | 9.5 |
| Prepaid Expenses | 5.3 | 3.59 | 2.38 |
| Total Assets | 2,742.54 | 2,252.06 | 2,146.15 |
| Current Portof LT Debt/Capital Leases | 68.12 | 9.14 | 9.09 |
| Additional Paid-In Capital | 5.7 | 5.7 | 5.7 |
| Cash | 269.79 | 350.25 | 330.62 |
| Total Equity | 1,976.46 | 1,845.06 | 1,721.86 |
| Long Term Investments | 4.6 | 4.81 | 5.02 |
| Retained Earnings(Accumulated Deficit) | 1,964.28 | 1,832.88 | 1,709.68 |
| Total Common Shares Outstanding | 3.24 | 3.24 | 3.24 |
| Property/Plant/Equipment Total-Gross | 2,012.4 | 1,643.22 | 1,457.11 |
| Tangible Book Valueper Share Common Eq | 609.11 | 568.47 | 530.83 |
| Total Liabilities | 766.08 | 407 | 424.29 |
| Total Debt | 133.28 | 11.03 | 19.7 |
| Cashand Short Term Investments | 269.79 | 350.25 | 330.62 |
| Total Receivables Net | 408.57 | 304.13 | 358.78 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Deferred Income Tax | 113.83 | 98.38 | 87.5 |
| Accounts Receivable-Trade Net | 346.08 | 275.63 | 319.71 |
| Property/Plant/Equipment Total-Net | 1,547.1 | 1,232.81 | 1,093.66 |
| Minority Interest | 175.26 | 173.31 | 171.38 |
| Total Current Liabilities | 402.04 | 129.69 | 148.7 |
| Total Inventory | 255.65 | 277.91 | 295.71 |
| Accounts Payable | 85.01 | 69.12 | 77.79 |
| Other Currentliabilities Total | 219.01 | 25.38 | 30.08 |
| Total Long Term Debt | 65.16 | 1.88 | 10.61 |
| Intangibles Net | 2.87 | 3.17 | 1.92 |
| Other Long Term Assets Total | 20.36 | 70.37 | 48.58 |
| Note Receivable-Long Term | 226.71 | Not available | Not available |
| Total Current Assets | 940.89 | 940.91 | 996.98 |
| Capital Lease Obligations | 0.33 | 0.37 | Not available |
| Other Equity Total | Not available | Not available | 0 |
| Short Term Investments | Not available | Not available | 0 |
Debt 5Yr CAGR %0.96
Operating Margin 12m17.76
Operating Margin 5y Avg19.95
Net Profit Margin 12m13.84
Net Profit Margin 5y15.14
Dividend Yield %0.55
Price to Sale Ratio4.72
Overall RiskHigh risk
Board Risk60.14
ConsensusHold
Consensus score3.00
Analyst opinions4
Strong Sell count1
Sell count1
Hold count0
Buy count1
Strong Buy count1
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,749 | 2.64 L | 58.09 | — |
| Solar Industries India | INR 18,560 | 1.68 L | 99.61 | — |
| Pidilite Industries | INR 1,671 | 1.70 L | 64.76 | — |
| SRF | INR 2,626 | 77,841.16 | 44.57 | — |
| Linde India | INR 7,105 | 61,033.66 | 110.53 | — |
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Buy Balaji Amines; target of Rs 3327: CD Equisearch Moneycontrol.com
Balaji Amines announces 38th AGM on July 10, 2026 scanx.trade
Buy, Sell Or Hold: Bharti Airtel, Solar Industries, Balaji Amines, Bharat Dynamics, UNO Minda, GMDC — Ask Profit NDTV Profit
Balaji Amines Soars 12%, Alkyl Amines Gains 8%: What's Fueling the Rally? Dalal Street Investment Journal
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Balaji Amines Limited is an India-based company, which is engaged in the business of manufacturing of Aliphatic Amines. The Company specializes in manufacturing Methyl Amines, Ethyl Amines, Derivatives of Aliphatic Amines and Specialty Chemicals. The Company's segments include Chemicals and Hotel. It also owns a five-star Hotel in Solapur, Maharashtra. Its products include amines, derivatives, specialty chemicals and pharma excipients. Its amine products include MONOMETHYLAMINE (MMA), DIMETHYLAMINE (DMA), TRIMETHYLAMINE and others. Its specialty chemical products include N-Methyl Pyrrolidone (NMP), Morpholine, 2-PYRROLIDONE, N-ETHYL-2-PYRROLIDONE, GAMMA-BUTYROLACTONE, ACETONITRILE (ACN) and others. Its derivative products include Di-Methyl Acetamide (DMAC); Di-Methyl Amine Hydrochloride (DMA HCL); Tri-Methyl Amine Hydrochloride (TMA HCL), and others. Its pharma excipients products include POLY VINYL PYRROLIDONE(PVP-30) IP/BP/JP GRADE and POLY VINYL PYRROLIDONE(PVP-30)-TECHNICAL GRADE.
Balaji Amines has the symbol BALAMINES and ISIN - INE050E01027.
Balaji Amines is currently trading at INR 2,151.00.
Balaji Amines has a year high of INR 2,629.80 and a year low of INR 968.10.
Balaji Amines has a market capitalization of INR 6,729.42 crore.
Balaji Amines has a P/E ratio of 32.42.
Balaji Amines has a dividend yield of 0.55%.
Balaji Amines has revenue of INR 1,424.98 crore, net income of INR 167.20 crore, and EPS of INR 62.79.
Balaji Amines has a book value of NA.
Balaji Amines has a debt-to-equity ratio of NA.
Balaji Amines has a price-to-book ratio of NA and a price-to-sales ratio of 4.72.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.